W. Lowry Caudill logo

W. Lowry Caudill

North America, North Carolina, United States, Durham

Description

Lowry Caudill is the retired, worldwide President of Pharmaceutical Development for Cardinal Health. The Pharmaceutical Development business...

Investor Profile

W. Lowry Caudill has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biopharma, Biotechnology, Health Care.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Health Care
  • Nanotechnology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does W. Lowry Caudill frequently co-invest with?

Next47
North America, California, United States, Palo Alto
Co-Investments: 1
Wakefield Group
North America, North Carolina, United States, Charlotte
Co-Investments: 1
Firelake Capital Management
North America, California, United States, Palo Alto
Co-Investments: 1
Siemens
Europe, Bayern, Germany, Munich
Co-Investments: 1

Which angels does W. Lowry Caudill often collaborate with?

Shared Deals: 1
WS
North America, North Carolina, United States, Chapel Hill
Shared Deals: 1

What are some of recent deals done by W. Lowry Caudill?

Liquidia Technologies

Morrisville, North Carolina, United States

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

BiopharmaBiotechnologyHealth CareNanotechnologyTherapeutics
Series AJun 14, 2006
Amount Raised: $6,000,000